While PSMA is constitutively expressed in non-malignant tissues—including prostate epithelium, salivary glands, lacrimal glands, and renal proximal tubules—it is markedly overexpressed in prostate cancer cells and the neovasculature of various solid tumours [103]. Here, FOLH1 is linked to prostate carcinoma.